$1.64
4.09% yesterday
Nasdaq, Dec 20, 10:00 pm CET
ISIN
US4626841013
Symbol
IRIX

IRIDEX Corporation Stock price

$1.64
-0.10 5.75% 1M
-0.33 16.75% 6M
-1.17 41.64% YTD
-0.97 37.16% 1Y
-4.02 71.02% 3Y
-0.76 31.67% 5Y
-6.96 80.93% 10Y
Nasdaq, Closing price Fri, Dec 20 2024
-0.07 4.09%
ISIN
US4626841013
Symbol
IRIX
Sector

Key metrics

Market capitalization $27.28m
Enterprise Value $28.33m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.58
P/S ratio (TTM) P/S ratio 0.56
P/B ratio (TTM) P/B ratio 10.40
Revenue growth (TTM) Revenue growth -11.31%
Revenue (TTM) Revenue $48.43m
EBIT (operating result TTM) EBIT $-10.88m
Free Cash Flow (TTM) Free Cash Flow $-7.00m
Cash position $3.86m
EPS (TTM) EPS $-0.68
P/S forward 0.53
EV/Sales forward 0.50
Short interest 1.83%
Show more

Is IRIDEX Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

IRIDEX Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast IRIDEX Corporation:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast IRIDEX Corporation:

Hold
100%

Financial data from IRIDEX Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
48 48
11% 11%
100%
- Direct Costs 30 30
4% 4%
62%
18 18
21% 21%
38%
- Selling and Administrative Expenses 21 21
6% 6%
44%
- Research and Development Expense 6.03 6.03
8% 8%
12%
-9.06 -9.06
50% 50%
-19%
- Depreciation and Amortization 1.82 1.82
21% 21%
4%
EBIT (Operating Income) EBIT -11 -11
31% 31%
-22%
Net Profit -11 -11
42% 42%
-23%

In millions USD.

Don't miss a Thing! We will send you all news about IRIDEX Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IRIDEX Corporation Stock News

Neutral
GlobeNewsWire
3 days ago
MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today announced the publication of a landmark peer-reviewed study in Ophthalmology Therapy. This study highlights the sustained safety and efficacy of...
Neutral
GlobeNewsWire
about one month ago
MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today confirms that Local Coverage Determination (LCD) L37531, relating to Micro-Invasive Glaucoma Surgery (MIGS), was adopted as s...
Neutral
Seeking Alpha
about one month ago
IRIDEX Corporation (NASDAQ:IRIX ) Q3 2024 Earnings Call Transcript November 12, 2024 5:00 PM ET Company Participants Scott Shuda - Executive Chairman Patrick Mercer - CEO Fuad Ahmad - Interim CFO Operator Thank you all for participating in today's call. Joining me from the company are Scott Shuda, Executive Chairman; Patrick Mercer, Chief Executive Officer; and Fuad Ahmad, Interim Chief Financi...
More IRIDEX Corporation News

Company Profile

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Head office United States
CEO Patrick Mercer
Employees 111
Founded 1989
Website www.iridex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today